000 01427 a2200373 4500
005 20250512204538.0
264 0 _c19820212
008 198202s 0 0 eng d
022 _a0024-3205
024 7 _a10.1016/0024-3205(81)90064-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGreen, D A
245 0 0 _aComparison of the muscarinic-cholinergic and lysophosphatidate inhibition of fibroblast adenylate cyclase demonstrating desensitization to the cholinergic stimulus.
_h[electronic resource]
260 _bLife sciences
_cOct 1981
300 _a1629-39 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenylyl Cyclase Inhibitors
650 0 4 _aAlprostadil
650 0 4 _aAtropine
_xpharmacology
650 0 4 _aCarbachol
_xpharmacology
650 0 4 _aCyclic AMP
_xmetabolism
650 0 4 _aEpinephrine
_xpharmacology
650 0 4 _aFibroblasts
_xdrug effects
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aLysophospholipids
650 0 4 _aPhosphatidic Acids
_xpharmacology
650 0 4 _aProstaglandins E
_xpharmacology
650 0 4 _aReceptors, Cholinergic
_xdrug effects
650 0 4 _aReceptors, Muscarinic
_xdrug effects
700 1 _aClark, R B
773 0 _tLife sciences
_gvol. 29
_gno. 16
_gp. 1629-39
856 4 0 _uhttps://doi.org/10.1016/0024-3205(81)90064-3
_zAvailable from publisher's website
999 _c6273604
_d6273604